1-10 of 10
Matthew Riddle
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508

Philip Home, Matthew Riddle, William T. Cefalu, Clifford J. Bailey, Reinhard G. Bretzel, Stefano del Prato, Derek Leroith, Guntram Schernthaner, Luc van Gaal, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2014;37(11):e247
https://doi.org/10.2337/dc14-1790
Published: 10 October 2014
View article titled, Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508
Open the PDF for Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508 in another window
Journal Articles

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects. Diabetes Care 2011;34: 2496–2501

Amparo de la Peña, Matthew Riddle, Linda A. Morrow, Honghua H. Jiang, Helle Linnebjerg, Adam Scott, Khin M. Win, Marcus Hompesch, Kenneth F. Mace, Jennie G. Jacobson, Jeffrey A. Jackson
Journal: Diabetes Care
Diabetes Care 2014;37(8):2414
https://doi.org/10.2337/dc14-er08
Published: 12 July 2014
View article titled, Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects. Diabetes Care 2011;34: 2496–2501
Open the PDF for Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects. Diabetes Care 2011;34: 2496–2501 in another window
Journal Articles

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

Philip Home, Matthew Riddle, William T. Cefalu, Clifford J. Bailey, Reinhard G. Bretzel, Stefano del Prato, Derek Leroith, Guntram Schernthaner, Luc van Gaal, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2014;37(6):1499–1508
https://doi.org/10.2337/dc13-2743
Published: 10 May 2014
View article titled, Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?
Open the PDF for Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? in another window
Journal Articles

Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study

Lamiae Grimaldi-Bensouda, David Cameron, Michel Marty, Anthony H. Barnett, Frédérique Penault-Llorca, Michael Pollak, Bernard Charbonnel, Matthew Riddle, Laurent Mignot, Jean-François Boivin, Artak Khachatryan, Michel Rossignol, Jacques Bénichou, Annick Alpérovitch, Lucien Abenhaim, for the ISICA Group
Journal: Diabetes Care
Diabetes Care 2014;37(1):134–143
https://doi.org/10.2337/dc13-0695
Published: 11 December 2013
View article titled, Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study
Open the PDF for Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study in another window
Includes: Supplementary data
Journal Articles

Signals and Noise in Drug Safety Analyses: The incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance

William T. Cefalu, MD, Julio Rosenstock, MD, Robert R. Henry, MD, Matthew Riddle, MD
Journal: Diabetes Care
Diabetes Care 2013;36(7):1804–1806
https://doi.org/10.2337/dc13-0895
Published: 12 June 2013
View article titled, Signals and Noise in Drug Safety Analyses: <subtitle>The incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance</subtitle>
Open the PDF for Signals and Noise in Drug Safety Analyses: <subtitle>The incretin therapy debate provides the rationale for revamping epidemiologic pharmacovigilance</subtitle> in another window
Journal Articles

Response to Comment on: Riddle et al. Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes. Diabetes Care 2011;34:2508–2514

Matthew Riddle, MD, Guillermo Umpierrez, MD, Andres DiGenio, MD, PHD, Rong Zhou, MD, Julio Rosenstock, MD
Journal: Diabetes Care
Diabetes Care 2012;35(1):e3
https://doi.org/10.2337/dc11-1968
Published: 09 December 2011
View article titled, Response to Comment on: Riddle et al. Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes. Diabetes Care 2011;34:2508–2514
Open the PDF for Response to Comment on: Riddle et al. Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes. Diabetes Care 2011;34:2508–2514 in another window
Journal Articles

Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes

Matthew Riddle, MD, Guillermo Umpierrez, MD, Andres DiGenio, MD, Rong Zhou, MD, Julio Rosenstock, MD
Journal: Diabetes Care
Diabetes Care 2011;34(12):2508–2514
https://doi.org/10.2337/dc11-0632
Published: 14 November 2011
View article titled, Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes
Open the PDF for Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects

Amparo de la Peña, PHD, Matthew Riddle, MD, Linda A. Morrow, MD, Honghua H. Jiang, PHD, Helle Linnebjerg, PHD, Adam Scott, BS, Khin M. Win, MBBS, Marcus Hompesch, MD, Kenneth F. Mace, PHD, Jennie G. Jacobson, PHD, Jeffrey A. Jackson, MD
Journal: Diabetes Care
Diabetes Care 2011;34(12):2496–2501
https://doi.org/10.2337/dc11-0721
Published: 14 November 2011
View article titled, Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
Open the PDF for Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects in another window
Includes: Supplementary data
Journal Articles

Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes

Matthew Riddle, MD, Richard Pencek, PHD, Supoat Charenkavanich, PHD, Karen Lutz, PHD, Ken Wilhelm, MD, Lisa Porter, MD
Journal: Diabetes Care
Diabetes Care 2009;32(9):1577–1582
https://doi.org/10.2337/dc09-0395
Published: 05 June 2009
View article titled, Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes
Open the PDF for Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes in another window
Journal Articles

Pramlintide Improved Glycemic Control and Reduced Weight in Patients With Type 2 Diabetes Using Basal Insulin

Matthew Riddle, MD, Juan Frias, MD, Bei Zhang, MD, Holly Maier, PHD, Carl Brown, PHD, Karen Lutz, PHD, Orville Kolterman, MD
Journal: Diabetes Care
Diabetes Care 2007;30(11):2794–2799
https://doi.org/10.2337/dc07-0589
Published: 01 November 2007
View article titled, Pramlintide Improved Glycemic Control and Reduced Weight in Patients With Type 2 Diabetes Using Basal Insulin
Open the PDF for Pramlintide Improved Glycemic Control and Reduced Weight in Patients With Type 2 Diabetes Using Basal Insulin in another window